SLC19A2 and thiamine-responsive megaloblastic anemia syndrome: We identified a nonsense mutation, c.697C > T (p.Gln233*), in SLC19A2 in a series of TRMA patients with congenital/early neonatal hearing loss and neonatal/early childhood diabetes and anemia.